Overview

A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

Status:
COMPLETED
Trial end date:
2025-02-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness, safety and tolerability of zilucoplan auto-injector (ZLP-AI) self-administration.
Phase:
PHASE3
Details
Lead Sponsor:
UCB Biopharma SRL
Treatments:
zilucoplan